Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.

Mendis S, Chestnov O.

Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):314-21. doi: 10.1016/j.pcad.2013.09.001. Review.

PMID:
24267438
[PubMed - indexed for MEDLINE]
2.

Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.

Ortegón M, Lim S, Chisholm D, Mendis S.

BMJ. 2012 Mar 2;344:e607. doi: 10.1136/bmj.e607.

PMID:
22389337
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The global burden of cardiovascular diseases: a challenge to improve.

Mendis S, Chestnov O.

Curr Cardiol Rep. 2014 May;16(5):486. doi: 10.1007/s11886-014-0486-3.

PMID:
24718672
[PubMed - indexed for MEDLINE]
4.

NCDs in low and middle-income countries - assessing the capacity of health systems to respond to population needs.

Allotey P, Davey T, Reidpath DD.

BMC Public Health. 2014;14 Suppl 2:S1. doi: 10.1186/1471-2458-14-S2-S1. Epub 2014 Jun 20. No abstract available.

PMID:
25082328
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Progress in national and regional guidelines development and deployment for the clinical prevention and control of CVD and diabetes in Africa.

Valluri S, Gaziano TA.

Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):336-43. doi: 10.1016/j.pcad.2013.09.014. Epub 2013 Sep 28.

PMID:
24267441
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cardiovascular diseases and diabetes as economic and developmental challenges in Africa.

Kengne AP, June-Rose McHiza Z, Amoah AG, Mbanya JC.

Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):302-13. doi: 10.1016/j.pcad.2013.10.011. Epub 2013 Oct 23. Review.

PMID:
24267437
[PubMed - indexed for MEDLINE]
7.

Challenges for the management of hypertension in low-resource settings.

Mendis S.

Ethn Dis. 2003 Summer;13(2 Suppl 2):S67-70. Review.

PMID:
13677416
[PubMed - indexed for MEDLINE]
8.

Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Korczak D, Dietl M, Steinhauser G.

GMS Health Technol Assess. 2011 Apr 1;7:Doc02. doi: 10.3205/hta000093.

PMID:
21468290
[PubMed]
Free PMC Article
9.

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.

Couser WG, Remuzzi G, Mendis S, Tonelli M.

Kidney Int. 2011 Dec;80(12):1258-70. doi: 10.1038/ki.2011.368. Epub 2011 Oct 12.

PMID:
21993585
[PubMed - indexed for MEDLINE]
10.

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

Breman JG, Alilio MS, Mills A.

Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15. Review.

PMID:
15331814
[PubMed - indexed for MEDLINE]
Free Article
11.

Non-communicable diseases and health systems reform in low-and-middle-income countries.

Robinson HM, Hort K.

Pac Health Dialog. 2012 Apr;18(1):179-90.

PMID:
23240355
[PubMed - indexed for MEDLINE]
12.

Cost-effectiveness of malaria control in sub-Saharan Africa.

Goodman CA, Coleman PG, Mills AJ.

Lancet. 1999 Jul 31;354(9176):378-85.

PMID:
10437867
[PubMed - indexed for MEDLINE]
13.

Health promotion and cardiovascular disease prevention in sub-Saharan Africa.

Sampson UK, Amuyunzu-Nyamongo M, Mensah GA.

Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):344-55. doi: 10.1016/j.pcad.2013.10.007. Epub 2013 Oct 9. Review.

PMID:
24267442
[PubMed - indexed for MEDLINE]
14.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.

Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X.

Diabetes Care. 2010 Aug;33(8):1872-94. doi: 10.2337/dc10-0843. Review.

PMID:
20668156
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Comprehensive strategies for the prevention and control of diabetes and cardiovascular diseases in Africa: future directions.

Muna WF.

Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):363-6. doi: 10.1016/j.pcad.2013.10.012. Epub 2013 Oct 18. Review.

PMID:
24267444
[PubMed - indexed for MEDLINE]
17.

Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Saha S, Gerdtham UG, Johansson P.

Int J Environ Res Public Health. 2010 Aug;7(8):3150-95. doi: 10.3390/ijerph7083150. Epub 2010 Aug 9. Review.

PMID:
20948954
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.

Caporale JE, Elgart JF, Gagliardino JJ.

Global Health. 2013 Oct 29;9:54. doi: 10.1186/1744-8603-9-54. Review.

PMID:
24168330
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.

Gaziano TA.

Heart. 2008 Feb;94(2):140-4. doi: 10.1136/hrt.2007.128785. Review.

PMID:
18195120
[PubMed - indexed for MEDLINE]
20.

Recognizing global burden of cardiovascular disease and related chronic diseases.

Kelly BB, Narula J, Fuster V.

Mt Sinai J Med. 2012 Nov-Dec;79(6):632-40. doi: 10.1002/msj.21345. Review.

PMID:
23239202
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk